Ir al contenido principal

Janus kinase 3

El JAK3 gene provides instructions for making a protein that is critical for the normal development and function of the immune system. The JAK3 protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. Signals relayed by the JAK3 protein regulate the growth and maturation of certain types of white blood cells (lymphocytes) called T cells and natural killer cells. In addition, JAK3 is important for the normal maturation of another type of lymphocyte called B cells. T cells, B cells, and natural killer cells attack bacteria, viruses, and fungi and help regulate the entire immune system.

Selecciones de videos para Genes
Biblioteca de videos

Normal function

El JAK3 gene provides instructions for making a protein that is critical for the normal development and function of the immune system. The JAK3 protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. Signals relayed by the JAK3 protein regulate the growth and maturation of certain types of white blood cells (lymphocytes) called T cells and natural killer cells. In addition, JAK3 is important for the normal maturation of another type of lymphocyte called B cells. T cells, B cells, and natural killer cells attack bacteria, viruses, and fungi and help regulate the entire immune system.

Conditions referring to this gene or chromosome

Otros nombres

JAK-3

JAK3_HUMAN

JAKL

Janus kinase 3 (a protein tyrosine kinase, leukocyte)

L-JAK

leukocyte Janus kinase

LJAK

tyrosine-protein kinase JAK3

Related patient information and medicines

Pompholyx

Patient information leaflet

Pompholyx

Its effectiveness for pompholyx is still being studied, so it is not recommended yet. Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these medications, available as creams or pills, target specific.

Artritis idiopática juvenil

Patient information leaflet

Artritis idiopática juvenil

Psoriasis, eye inflammation and bowel inflammation may ... ServiceUpsellPlaceholder How is juvenile idiopathic arthritis diagnosed. The diagnosis of juvenile idiopathic arthritis (JIA) is based on the symptoms and an examination by your doctor. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is.

Distrofia muscular

Patient information leaflet

Distrofia muscular

Becker's muscular dystrophy (BMD) BMD is similar in many ways to DMD, but is less severe. Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to anot... MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Trastornos del almacenamiento de glucógeno

Patient information leaflet

Trastornos del almacenamiento de glucógeno

Trastornos del almacenamiento de glucógeno are a group of enfermedad cardíaca diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Cáncer de hígado primario

Patient information leaflet

Cáncer de hígado primario

It is not likely to be curative for primary liver cancer but may shrink the tumour down to slow the progression of the disease. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase inhibitor. It interferes with the growth of cancer cells. Research has.

Myelofibrosis

Patient information leaflet

Myelofibrosis

...affecting the bone marrow and its blood cell productionThe gene mutation that occurs in most people affected by myelofibrosis is a mutation in Janus Kinase 2 (JAK2). Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.
  • 18 Aug 2020 | Última versión
  • 1 Aug 2017 | Publicado originalmente

Únete a la conversación

Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.

Aviso legal: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia en línea, tratamientos y servicios de salud

Acceso sencillo a tratamientos y servicios de salud confiables en línea.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.